David Ruiz-González

David Ruiz-González

Auto-generated profile, based on publicly available information

David Ruiz-González

Department of Education, Faculty of Education Sciences, University of Almería, Almería, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
DRDavid Ruiz-González
David Ruiz-González
AHAlba Hernández
Alba Hernández
Pedro L. ValenzuelaPedro L. Valenzuela
Pedro L. Valenzuela
JMJavier S Morales
Javier S Morales
Alberto Soriano-MaldonadoAlberto Soriano-Maldonado
Alberto Soriano-Maldonado
Neurodegenerative disorders are associated with reduced levels of brain-derived neurotrophic factor (BDNF). We aimed to assess the effect of exercise interventions on plasma BDNF levels in individuals with neurodegenerative disorders. Eighteen randomized controlled trials (RCT) assessing the effects of exercise interventions versus no exercise on plasma BDNF levels in individuals with neurodegenerative disorders (i.e., multiple sclerosis, Parkinson's disease, mild cognitive impairment [MCI] and Alzheimer's disease) were included. Overall, exercise interventions induced a significant increase in plasma BDNF levels (SMD=2.22, 95% CI=1.33-3.12, p<0.001; 18 studies), which was separately confirmed for multiple sclerosis (SMD= 2.40, 95% CI= 1.30-3.50, p<0.001; 10 studies) and Parkinson's disease (SMD= 10.00, 95% CI= 2.48-17.51, p=0.009; 3 studies), with a non-significant trend also observed for MCI (SMD= 1.07, 95% CI= -0.14-2.28, p=0.080; 4 studies). BDNF levels significantly increased regardless of exercise type (p<0.001, p=0.003 and p=0.020 for combined, aerobic and resistance exercise, respectively), weekly exercise volume (p<0.001 for both ≥150 and <150 min/week) and intervention length (p<0.001 for both interventions of ≥12 and <12 weeks). In conclusion, physical exercise interventions increase plasma BDNF levels in individuals with neurodegenerative disorders. PROSPERO registration number: CRD42020199459.

16 April 2024 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
DRDavid Ruiz-González
David Ruiz-González
ICIván Cavero-Redondo
Iván Cavero-Redondo
AHAlba Hernández-Martínez
Alba Hernández-Martínez
ABAndrés Baena-Raya
Andrés Baena-Raya
SMSonia Martínez-Forte
Sonia Martínez-Forte
Alberto Soriano-MaldonadoAlberto Soriano-Maldonado
Alberto Soriano-Maldonado
The increasing prevalence of obesity worldwide poses a significant threat to reproductive function owing, in part, to hormonal disturbances caused by negative feedback between excess adiposity and the hypothalamic–pituitary–ovarian axis. Consequently, finding the most appropriate strategies to lose weight and improve ovulation in women with overweight or obesity is a clinically relevant matter that needs to be investigated. A comprehensive comparison of the independent and combined efficacy of lifestyle and/or pharmacological interventions on BMI, ovulation, and hormonal profile in women with overweight or obesity at risk of anovulatory infertility would facilitate improving fertility strategies in this population. This study aimed to evaluate the comparative efficacy of exercise, diet, and pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity. A systematic review was performed by searching PubMed, Scopus, Web of Science, PsycINFO, and Cochrane Library up to 14 December 2023, for randomized controlled trials assessing the effects of exercise, diet and/or pharmacological interventions (i.e. weight-lowering drugs or ovulation inducers) on BMI, ovulation, and/or hormonal profile in reproductive-aged women with overweight or obesity. We performed frequentist random-effect network meta-analyses and rated the certainty of the evidence. The primary outcomes were BMI and ovulation rate, and the secondary outcomes were serum reproductive hormone levels (gonadotrophins, androgens, or oestrogens). We performed sensitivity analyses, including the studies that only involved women with PCOS. Among 1190 records screened, 148 full texts were assessed for eligibility resulting in 95 trials (9910 women), of which 53% presented a high or unclear risk of bias. The network meta-analyses revealed that, compared to control: diet combined with weight-lowering drugs (mean difference (MD) −2.61 kg/m2; 95% CI −3.04 to −2.19; τ2 = 0.22) and adding exercise (MD −2.35 kg/m2; 95% CI −2.81 to −1.89; τ2 = 0.22) led to the greatest decrease in BMI; exercise combined with diet and ovulation inducers (risk ratio (RR) 7.15; 95% CI 1.94–26.40; τ2 = 0.07) and exercise combined with diet and weight-lowering drugs (RR 4.80; 95% CI 1.67–13.84; τ2 = 0.07) produced the highest increase in ovulation rate; and exercise combined with diet and weight-lowering drugs was the most effective strategy in reducing testosterone levels (standardized mean difference (SMD) −2.91; 95% CI −4.07 to −1.74; τ2 = 2.25), the third most effective strategy in increasing sex hormone-binding globulin levels (SMD 2.37; 95% CI 0.99–3.76; τ2 = 2.48), and it was coupled with being ranked first in terms of free androgen index reduction (SMD −1.59; 95% CI −3.18 to 0.01; τ2 = 1.91). The surface under the cumulative ranking curve scores suggested that: diet combined with weight-lowering drugs is the strategy most likely (94%) to produce the highest BMI reduction; and exercise combined with diet and ovulation inducers is the strategy most likely (89%) to produce the highest ovulation rate improvement. The sensitivity analyses, which exclusively included studies involving women diagnosed with PCOS, were consistent with the results presented above. Overall, the findings of this network meta-analysis indicate that the combination of exercise, diet, and pharmacological interventions is effective for weight loss, improving ovulation, and normalizing the androgen levels of women with overweight or obesity. Although higher quality studies are needed, these results support that the optimal treatment strategy for women with overweight or obesity wishing to conceive must consider exercise, diet, and pharmacological interventions during the shared decision-making process. The combination of exercise, diet, and pharmacological interventions is effective for weight loss, improving ovulation, and normalizing the androgen levels of women with overweight or obesity. RCT, randomized controlled trials; SUCRA, surface under the cumulative ranking curve.

7 August 2024 in BMJ Open Sport & Exercise Medicine
Verified
Journal Article
Open access
PDF file
AHAlba Hernández
Alba Hernández
MFManuel Fernandez-Escabias
Manuel Fernandez-Escabias
LPLaura Amaya Pascasio
Laura Amaya Pascasio
SCSofia Carrilho-Candeias
Sofia Carrilho-Candeias
MRMáriam Ramos-Teodoro
Máriam Ramos-Teodoro
Alberto Soriano-MaldonadoAlberto Soriano-Maldonado
Alberto Soriano-Maldonado
Stroke is the leading cause of disability and the second cause of death worldwide. The increasing burden of stroke underscores the importance of optimising rehabilitation protocols. Virtual reality (VR) can improve poststroke prognosis. A VR software combining gamification, full immersion and stroke specificity (ie, the Development and validation of a novel viRtual rEality software for improving diSability and quality of lifE in patients with sTroke (RESET) software) might substantially improve disability and quality of life (QoL). However, this technology is still very scarce. The RESET trial aims to assess the effects of an early 10-week gamified, fully immersive and stroke-specific VR intervention (ie, starting at week 3 poststroke) on disability and QoL in people with stroke in the subacute phase. People with ischaemic or haemorrhagic stroke (n=94) aged ≥18 years will be randomised to receive (1) usual care (UC), (2) commercial VR or (3) gamified, fully immersive and stroke-specific VR (RESET). The three groups will receive UC (ie, three sessions/week of 90 min of standard rehabilitation). The VR groups will additionally receive three VR sessions of 20 min per week. The outcome measures will be assessed at baseline (week 2 from stroke occurrence), week 13 (approximately 90 days from the event) and week 26 (approximately 6 months from the event). The primary outcome is disability measured with the Barthel Index. Secondary outcomes include QoL, upper-extremity and lower-extremity motor function, gross manual dexterity, handgrip strength and cognitive function. This study will unravel the effects of a gamified, fully immersive and stroke-specific VR software on disability and QoL in patients with stroke in the early subacute phase. NCT06132399.

18 March 2026 in British Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
SRSamuel Ruiz-Campos
Samuel Ruiz-Campos
JSJoaquin Sanchez-Gomez
Joaquin Sanchez-Gomez
DRDavid Ruiz-González
David Ruiz-González
ARAna León Rodríguez
Ana León Rodríguez
JSJuan Luis Sánchez Sánchez
Juan Luis Sánchez Sánchez
JMJavier S Morales
Javier S Morales
Objective To synthesise the evidence on the effects of exercise interventions in children and adolescents during and beyond cancer treatment, and to evaluate the methodological quality and certainty of this evidence. Design Umbrella review of systematic reviews with meta-analyses. Data source PubMed, Web of Science, Scopus, SPORTDiscus and CINAHL were searched from inception to January 2026. Eligibility criteria for selecting studies Systematic reviews with meta-analysis of controlled trials (randomised or non-randomised) evaluating exercise interventions in children and adolescents (≤19 years) during and beyond cancer treatment. Reviews without quantitative synthesis, those including only observational studies, or interventions where the isolated effect of exercise could not be determined were excluded. Results 19 systematic reviews with meta-analyses, including 53 primary studies (n=2361 participants), were identified, yielding 80 effect estimates. Attending to the most comprehensive meta-analyses, exercise induced significant benefits on cardiorespiratory fitness (mean difference (MD) 6.92% (95% CI 1.01% to 12.82%)), cognitive function (standardised mean difference (SMD) 0.26 (95% CI 0.08 to 0.44)) and cognitive performance (SMD 0.41 (95% CI 0.17 to 0.65)), with moderate certainty of evidence. Exercise also induced significant benefits on muscle strength (SMD 0.81 (95% CI 0.05 to 1.57)), functional mobility (MD −1.17 s (95% CI −1.86 to −0.49)) and cancer-related fatigue (SMD −0.62 (95% CI −1.21 to −0.03)), although the certainty was low or very low. These effects were observed across meta-analyses focused exclusively on studies conducted during treatment (n=26), after treatment (n=3) or both (n=51). In contrast, no significant effects of exercise were observed for depression, bone mineral density, health-related quality of life, anthropometry or other clinical outcomes (such as mortality, relapse risk and withdrawal rates). Conclusion Exercise appears to be a beneficial intervention in childhood cancer for improving some physical, cognitive and psychosocial outcomes. However, more high-quality research is warranted to strengthen clinical recommendations and inform personalised exercise prescriptions, given that the certainty of evidence remains variable and overall low across outcomes. PROSPERO registration number CRD420251031412.

23 May 2022 in medRxiv
Verified
Preprint
Open access
PDF file
DRDavid Ruiz-González
David Ruiz-González
JRJavier Ramos-Maqueda
Javier Ramos-Maqueda
JMJairo H Migueles
Jairo H Migueles
JVJosé Antonio Vargas-Hitos
José Antonio Vargas-Hitos
ARAmalio Ruiz-Salas
Amalio Ruiz-Salas
Alberto Soriano-MaldonadoAlberto Soriano-Maldonado
Alberto Soriano-Maldonado
Introduction: Regular exercise and sports are contraindicated in arrhythmogenic cardiomyopathy (AC) patients, which might lead them to an unhealthy sedentary lifestyle. This study aimed to objectively describe the patterns of physical activity (PA), sedentary time (SED), and sleep in patients with AC, and to examine the reproducibility of accelerometer-derived measures over four consecutive weeks. Methods: A total of 71 (49.6 [SD=17.5] years) patients with AC wore a wrist-worn Axivity AX3 accelerometer for 30 consecutive days to monitor their physical activity, sedentary time, and sleep habits. The reproducibility of each metric across the 4 assessment weeks was assessed with the intraclass correlation coefficients (ICCs) derived from linear-mixed models adjusted for age, body mass index (BMI), and season. Results: The participants spent a median of 12.2 [IQR 2.1] h/d in SED, 6.4 [IQR 1.0] h/d sleeping, and 17.9 [IQR 24.5] min/d in moderate-to-vigorous physical activity (MVPA), and 59% of the participants did not reach the 150 min/d of MVPA recommended by the WHO for people living with chronic disease. No significant differences in PA were found by sex and age groups. Otherwise, patients aged ≥50 years (n= 33) spent 38.9 min/d (95% CI 5.8 to 72.2, p≤0.05) more in periods of ≥30 minutes of SED than those <50 years. Participants with obesity (n=10) accumulated 66.6 min/d (95% CI 5.2 to 128.1, p = <0.05) more SED in periods of ≥30 minutes and 22.8 min/d (95% CI 0.7 to 44.9, p≤0.05) less MVPA than those without obesity. The ICCs ranged from 0.67 for time in bed to 0.92 for light-intensity physical activity using a 7-day assessment period. However, the ICCs increased from 0.03 for LPA to 0.18 for time in bed when an assessment period of 14 days was chosen. Conclusion: Patients with AC engage in large periods of SED, insufficient PA and sleep. Importantly, nearly 60% of the participants did not meet the minimum amount of PA recommended by the WHO for people living with chronic diseases and only 20% met the sleep recommendations. Device-measured PA and SED are stable across weeks, indicating that a 7-day assessment period might provide a reproducible measure of PA and SED and, to a lower extent, sleep.

29 July 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JRJavier Ramos-Maqueda
Javier Ramos-Maqueda
JMJairo H Migueles
Jairo H Migueles
MMMaría Molina-Jiménez
María Molina-Jiménez
DRDavid Ruiz-González
David Ruiz-González
ECEva Cabrera-Borrego
Eva Cabrera-Borrego
JJJuan Jiménez Jáimez
Juan Jiménez Jáimez
Objectives: This study aimed to investigate the association of accelerometer-measured lifestyle physical activity with the incidence of rapid-rate non-sustained ventricular tachycardias (RR-NSVT) during a 30-day recording period in AC patients. Methods: This multicenter, observational study enrolled 72 AC patients, including right, left-, and biventricular forms of the disease, with underlying desmosomal and non desmosomal mutations. Lifestyle physical activity was objectively monitored with accelerometers (i.e., movement sensors), and RR-NSVT were identified from a textile Holter electrocardiogram (ECG) for 30 days as those faster than 188 bpm and longer than 18 beats. Results: Sixty-three AC patients (38±17.6 years, 57% men) provided data on physical activity and ventricular tachycardias. A total of 17 patients experienced 1 ≥ RR-NSVTs, and a total of 35 events were recorded. Participants presenting RR-NSVTs during the 30-day measurement (n=17) did not perform more lifestyle physical activity ( P =0.734), neither more activities of moderate-to-vigorous intensity ( P =0.245) than their peers without RR-NSVTs in this period. Likewise, participants with RR-NSVTs did not increase their activity level, neither the activities of any intensity (−5 min/day on average) nor those of moderate-to-vigorous intensity (+2 min/day on average) in the days of RR-NSVTs occurrence. Finally, we observed that around half of the RR-NSVTs recorded in the 30 days occurred at rest (i.e., 19 RR-NSVTs), and the other half occurred after or during physical activity (i.e.,16 RR-NSVTs). Conclusion: These findings suggest that lifestyle physical activity, mainly of light and moderate intensity, does not increase the risk for RR-NSVTs in AC patients. Summary box: What is already known: Arrhythmogenic cardiomyopathy (AC) is associated to sport-triggered sudden cardiac death Competitive sports and high-intensity exercise are contraindicated in AC patients Rapid-rate non-sustained ventricular arrhythmias (RR-NSVT) are a surrogate of sudden cardiac death in this population What this study adds: Conscious investigation on the relationship between lifestyle physical activity of different intensities with ventricular arrhythmias in AC patients Accelerometer-measured lifestyle physical activity, mainly of light and moderate intensity, seem not to be associated with the occurrence of RR-NSVTs How this study might affect clinical practice in the future: This study provides strong evidence for the promotion of lifestyle physical activity among AC patients to ensure they obtain the multiple benefits and risk reductions associated with physical activity